Cathepsin K-Mediated Phenotypic Switching of Pulmonary Artery Smooth Muscle Contributed to the Development of Chronic Stress-related Pulmonary Hypertension in Mice
Year: 2026
Type: preprint
Abstract: Aims Exposure to chronic psychological stress is a risk factor for metabolic pulmonary artery hypertension (PAH). Given the critical role of lysosomal cathepsin K (CTSK) in human pathobiology, we examined the role of CTSK in stress-related PAH, focusing on TGFβ/TGF-βR2-SMAD2/3 signaling-mediated switching of the phenotypical changes pf pulmonary artery smooth muscle cells (PASMCs). Methods and Results Eight-week-old male wild-type (CTSK +/+ ) and CTSK-knockout (CTSK −/− ) mice were subjected to hypoxia ± the tyrosine-kinase inhibitor SU-5416 with or without chronic restraint stress (CRS). Upon model establishment, the right-ventricular systolic pressure and vascular remodeling were quantified by echocardiography, micro-tip pressure sensor catheter, and biological and histomorphometry methods. Single-cell RNA sequencing (scRNA-seq) revealed elevated CTSK expression in PASMCs from idiopathic PAH patients. In mice, hypoxia ± SU-5416 induced CTSK expression and triggered PAH pathology that was markedly exacerbated by superimposed CRS. Genetic deletion of CTSK attenuated key features of PAH, including right-ventricular systolic pressure elevation and vascular remodeling, as well as a shift of PASMCs towards a synthetic phenotype characterized by increased expressions of extracellular-matrix genes (fibronectin, CTSK, and collagen I), a parallel induction of synthetic markers (TGF-β, VIM, and VCAN), and a decrease in contractile genes (SM22α, CNN1, and ATAC2). Mechanistically, CTSK formed a positive-feedback loop with TGF-β–SMAD2/3 signaling. In PASMCs, the silencing of CTSK abolished hypoxia- and stress-serum-induced cell proliferation and disrupted this loop, whereas CTSK overexpression amplified both. Conclusions These results identified CTSK as a critical contributor to PAH pathogenesis, particularly under chronic stress conditions. CTSK drives disease progression by enforcing a self-amplifying CTSK–TGF-β–SMAD2/3 circuit that switches PASMC phenotype change and proliferation.
Source: Research Square
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: cathepsin K, pulmonary arterial hypertension, chronic psychological stress, pulmonary artery smooth muscle cells, phenotypic switching, TGF-β/Smad2/3 signaling, hypoxia, vascular remodeling, smooth muscle cell proliferation, synthetic phenotype, lysosomal proteolysis, right ventricular systolic pressure
Open Access status: green
Award: G7346530235
OpenAlex ID: W7235145451
